Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Drops By 36.4%

Virax Biolabs Group Limited (NASDAQ:VRAX) was the target of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 284,000 shares, a drop of 36.4% from the October 31st total of 446,500 shares. Based on an average daily volume of 3,260,000 shares, the short-interest ratio is currently 0.1 days. Currently, 7.0% of the shares of the company are short sold.

Virax Biolabs Group Trading Down 1.4 %

Virax Biolabs Group stock opened at $2.04 on Friday. The stock has a 50-day simple moving average of $1.97 and a 200 day simple moving average of $1.95. Virax Biolabs Group has a 52 week low of $0.60 and a 52 week high of $9.00.

About Virax Biolabs Group

Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.